MNOV - MEDICINOVA INC
1.36
0.060 4.412%
Share volume: 40,162
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.30
0.06
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 02-19-2025 | 05-13-2025 | 08-14-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 62.894 M | 60.404 M | 58.119 M | 55.876 M | 52.431 M | 49.824 M | 47.578 M | |
| Current Assets | 47.864 M | 45.506 M | 43.265 M | 41.074 M | 37.679 M | 35.124 M | 32.923 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 47.139 M | 44.338 M | 42.281 M | 40.360 M | 36.571 M | 34.260 M | 32.563 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 40.384 K | 35.813 K | 30.813 K | 25.507 K | 20.386 K | 15.361 K | 12.933 K | |
| Other Assets | 14.990 M | 14.862 M | 14.823 M | 14.776 M | 14.731 M | 14.685 M | 14.643 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 62.894 M | 60.404 M | 58.119 M | 55.876 M | 52.431 M | 49.824 M | 47.578 M | |
| Total liabilities | 3.063 M | 2.999 M | 3.054 M | 3.372 M | 2.501 M | 2.967 M | 3.614 M | |
| Total current liabilities | 2.510 M | 2.494 M | 2.597 M | 2.959 M | 2.134 M | 2.648 M | 3.337 M | |
| Accounts Payable | 804.764 K | 667.695 K | 708.203 K | 1.102 M | 718.891 K | 569.445 K | 745.958 K | |
| Other liabilities | 351.185 K | 302.483 K | 255.150 K | 211.460 K | 165.198 K | 117.038 K | 74.399 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 351.185 K | 302.483 K | 255.150 K | 211.460 K | 165.198 K | 117.038 K | 74.399 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 59.830 M | 57.405 M | 55.066 M | 52.504 M | 49.930 M | 46.857 M | 43.965 M | |
| Common stock | 478.414 M | 478.621 M | 479.126 M | 479.390 M | 479.676 M | 479.881 M | 480.038 M | |
| Retained earnings | -418.456 M | -421.084 M | -423.937 M | -426.751 M | -429.615 M | -432.897 M | -435.947 M |